ARTICLE | Politics & Policy

Reviewers ask FDA for CV 'polypill' development pathway

September 9, 2014 2:14 AM UTC

FDA reviewers asked the agency's Cardiovascular and Renal Drugs Advisory Committee for advice on a development pathway for fixed-dose combination therapies for hypertension. In polypill and if sufficient adherence could be achieved without rigorous monitoring. ...